Adam I Riker Selected Research

Adam I Riker Research Topics

Disease

33	Melanoma (Melanoma, Malignant) 12/2016 - 02/2002
31	Neoplasms (Cancer) 07/2021 - 02/2002
11	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2002
9	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2008
3	Carcinogenesis 07/2021 - 06/2010
3	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 01/2010
2	Necrosis 03/2017 - 12/2008
2	Margins of Excision 01/2014 - 11/2006
2	Carcinoma (Carcinomatosis) 01/2009 - 02/2008
1	Anastomotic Leak 01/2023
1	Surgical Wound Infection 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Frailty 01/2023
1	Wounds and Injuries (Trauma) 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 07/2021
1	Microsatellite Instability 01/2021
1	Latent Infection 12/2020
1	Diabetes Mellitus 11/2020
1	Pathologic Processes 11/2020
1	Pain (Aches) 01/2020
1	Merkel Cell Carcinoma 01/2019
1	Triple Negative Breast Neoplasms 06/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2017
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2015
1	Anaphylaxis (Anaphylactic Shock) 01/2015
1	Actinic Keratosis 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Warts (Wart) 01/2015
1	Immunoglobulin Light-chain Amyloidosis 01/2014

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 06/2018 - 10/2004
5	MicroRNAs (MicroRNA)IBA 07/2021 - 01/2010
3	Histone Deacetylase InhibitorsIBA 01/2020 - 05/2009
3	VaccinesIBA 12/2016 - 01/2006
3	GlycodelinIBA 01/2015 - 06/2010
3	trichostatin A (A 300)IBA 05/2013 - 05/2009
3	Microphthalmia-Associated Transcription FactorIBA 01/2011 - 10/2004
3	Complementary DNA (cDNA)IBA 02/2010 - 06/2002
3	Peptides (Polypeptides)IBA 07/2006 - 02/2002
2	Sulindac (Copal)FDA LinkGeneric 05/2021 - 01/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2017 - 01/2009
2	Small Interfering RNA (siRNA)IBA 01/2011 - 06/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2011 - 02/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2010 - 02/2010
2	theasinensin AIBA 01/2010 - 05/2009
2	Decitabine FDA Link 01/2010 - 05/2009
2	OsteopontinIBA 01/2010 - 08/2009
2	DNA (Deoxyribonucleic Acid)IBA 12/2008 - 01/2006
2	AntigensIBA 07/2006 - 02/2002
1	SDMIBA 01/2022
1	SteroidsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 07/2021
1	sulindac sulfideIBA 05/2021
1	Cyclin G2IBA 05/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Metformin (Glucophage)FDA LinkGeneric 11/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2020
1	romidepsin (FK228)FDA Link 01/2020
1	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2020
1	PanobinostatIBA 01/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2019
1	pembrolizumabIBA 01/2019
1	ClaudinsIBA 06/2018
1	Estrogen ReceptorsIBA 03/2017
1	Coloring Agents (Dyes)IBA 01/2015
1	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 01/2015
1	Imiquimod (Aldara)FDA LinkGeneric 01/2015
1	InterferonsIBA 01/2014
1	arseniteIBA 02/2012
1	Ion Channels (Ion Channel)IBA 02/2012
1	Aquaporins (Water Channels)IBA 02/2012
1	IpilimumabIBA 08/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Adenosine Triphosphate (ATP)IBA 01/2011
1	AgarIBA 06/2010
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	Protein Isoforms (Isoforms)IBA 02/2010
1	Melanoma-Specific AntigensIBA 02/2010
1	Lactate Dehydrogenase 5IBA 02/2010
1	Cystatin CIBA 01/2010
1	Cathepsin BIBA 01/2010
1	CathepsinsIBA 01/2010
1	locked nucleic acidIBA 01/2010
1	Cysteine Proteinase InhibitorsIBA 01/2010
1	asparaginylendopeptidase (legumain)IBA 01/2010
1	matrigelIBA 01/2010
1	Cystatin MIBA 01/2010

Therapy/Procedure

17	Therapeutics 01/2021 - 02/2002
9	Immunotherapy 01/2021 - 01/2006
3	Radiotherapy 11/2020 - 05/2014
3	Drug Therapy (Chemotherapy) 11/2020 - 01/2009
2	Segmental Mastectomy (Lumpectomy) 03/2017 - 01/2014
2	Lymph Node Excision (Lymph Node Dissection) 11/2006 - 06/2006
1	Colostomy 01/2023
1	Colectomy 01/2023
1	Mammaplasty (Breast Reconstruction) 01/2022
1	Aftercare (After-Treatment) 01/2020